Io̍h-phín
Chit phiⁿ bûn-chiuⁿ m̄-sī teh kóng Io̍h-bu̍t.
Io̍h-phín (藥品) sī the̍h-lâi chò chín-toàn, tī-jú, tī-liâu ia̍h ī-hông chi̍t-pēⁿ ê io̍h-bu̍t.[1][2][3] Io̍h-bu̍t tī-liâu sī i-ha̍k ê tiōng-iàu khoân-chat, che ài óa-khò io̍h-lí-ha̍k ê chhî-sio̍k chìn-pō͘ kap io̍h-ha̍k ê sek-tòng khòng-chè.
Io̍h-phín ū chē-chē hun-lūi hong-sek. Chiàu io̍h-phín kám ū pī koán-chè, ē-tàng pun chò chhú-hng io̍h-phín kap it-poaⁿ io̍h-phín nn̄g lūi.
- ↑ Definition and classification of Drug or Pharmaceutical Regulatory aspects of drug approval Archived 2017-07-22 at the Wayback Machine. Accessed 30 December 2013.
- ↑ US Federal Food, Drug, and Cosmetic Act, SEC. 210., (g)(1)(B). Accessed 17 August 2008.
- ↑ Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Article 1. Published 31 March 2004. Accessed 17 August 2008.